Exploring Durvalumab With Radiation Therapy in Patients With Urothelial Carcinoma

February 9, 2018
Monika Joshi, MD

During the 2018 Genitourinary Cancers Symposium, Monika Joshi, MD, assistant professor, Penn State Hershey Medical Center, shared results of a phase Ib study of durvalumab (Imfinzi) and radiation therapy (DUART) followed by adjuvant durvalumab in patients with bladder cancer.